Mpox Resource Center
In light of the recent cases of mpox in the U.S., the National Coalition for LGBTQ Health has curated a library of evidence-based materials in multiple formats about mpox. Geared to clinicians, researchers, and community members, the resources provide information about mpox virus transmission, prevention, testing, and treatment.
Resources from CDC
Scientists at the Centers for Disease Control and Prevention (CDC) are tracking multiple cases of monkeypox that have been reported in several countries that don’t normally report mpox, including the United States.
It’s not clear how the people were exposed to mpox, but early data suggest that gay, bisexual, and other men who have sex with men make up a high number of cases. However, anyone who has been in close contact with someone who has mpox is at risk. CDC is urging healthcare providers in the U.S. to be alert for patients who have rash illnesses consistent with mpox, regardless of whether they have travel or specific risk factors for mypox and regardless of gender or sexual orientation.
CDC is working with state and local health officials to identify people who may have been in contact with individuals who have tested positive for mpox, so they can monitor their health.
New and Updated
Potential Risk for New Mpox Cases: CDC Health Alert Network 5/15/23 NEW
In the United States, cases of mpox (formerly monkeypox) have declined since peaking in August 2022, but the outbreak is not over. The CDC continues to receive reports of cases that reflect ongoing community transmission in the United States and internationally.
What treatments are available for mpox?
How long can mpox survive on clothing and surfaces?
JYNNEOS Vaccine Coverage by Jurisdiction
Treatment Information for Healthcare Professionals
What is intradermal administration of the JYNNEOS vaccine?
Risk of Mpox Resurgence and Continued Vaccination Efforts
Stay current on CDC’s mpox resources online by visiting the What’s New & Updated page.
Advisory Committee on Immunization Practices (ACIP) Meeting, Feb. 22-24, 2023
If You Are Sick
Funding Resources
Mpox Guidance for CDC Grant Recipients
Mpox Considerations for Sexual Health Services (Dear Colleague Letters)
HRSA: Use of Ryan White HIV/AIDS Program Funds for Mpox
HUD’s HOPWA (Housing Opportunities for Persons with AIDS)
SAMHSA: Dear Colleague Letter on Using SAMHSA Grant Resources for Mpox-related Activities
Community
- Can I get | Mpox | Poxvirus | CDC (video)
- Can I help | Mpox | Poxvirus | CDC (video)
- Need Doses | Mpox | Poxvirus | CDC (video)
- Vaccine Work | Mpox | Poxvirus | CDC (video)
- How are we doing | Mpox | Poxvirus | CDC (video) – this video is specific to a period of time, so may not be evergreen.
- How can I protect myself | Mpox | Poxvirus | CDC (video)
- How Long Protect | Mpox | Poxvirus | CDC (video)
- Can I be reinfected? | Mpox | Poxvirus | CDC (video)
- Is it too late | Mpox | Poxvirus | CDC (video)
- Vaccine Exposed | Mpox | Poxvirus | CDC (video)
- Is there enough | Mpox | Poxvirus | CDC (video)
- What should I expect | Mpox | Poxvirus | CDC (video)
- Where Can I Get | Mpox | Poxvirus | CDC (video)
- Learn about Mpox and Safer Sex | Mpox | Poxvirus | CDC (flyer)
- The Mpox Vaccine (JYNNEOS Vaccine) | Monkeypox | Poxvirus | CDC (flyer)
- Mpox Informational Poster for Correctional and Detention Facilities | Mpox | Poxvirus | CDC (poster)
Health Departments
VIDEOS
FAQ videos from Kaiser Family Foundation, rights-free and designed for sharing
Data and Analytics
2022 U.S. Mpox Outbreak UPDATED
U.S. Map & Case Count UPDATED
U.S. Mpox Case Trends Reported to CDC UPDATED
Global Map & Case Count UPDATED
JYNNEOS Vaccine Coverage by Jurisdiction UPDATED
Mpox Cases by Age and Gender, Race/Ethnicity, and Symptoms UPDATED
U.S. Wastewater Data UPDATED
Mpox Vaccine Administration U.S. Map UPDATED
Demographics of Patients Receiving TPOXX for Treatment of Mpox UPDATED
Non-Variola Orthopoxvirus and Mpox Virus Laboratory Testing Data UPDATED
Additional CDC Resources
Health Alert Network (HAN)—Severe Manifestations of Mpox
Mpox Vaccine Confidence Insights Report
Mpox Vaccine Equity Pilot Program
Science Brief: Detection and Transmission of Mpox Virus
Mpox Vaccination Program Provider Agreement
Clinician Outreach and Communication Activity (COCA) Call
Clinical Considerations for Treatment and Prophylaxis of Mpox Virus Infection in People with HIV
Additional Intradermal Administration Sites: JYNNEOS Vaccine
Video: How to Administer Intradermal Vaccine in Forearm, Deltoid, and Scapula
Videos on mpox recommendations and updates from CDC leadership and partners
Completing a Death Certificate in the Setting of Mpox
V-safe after Vaccination Health Checker for Mpox Vaccine
Mpox Toolkit for Correctional and Detention Facilities
Safer Sex, Social Gatherings, and Mpox
Strategies for Talking with Patients about Vaccinations for Mpox
CDC’s Vaccine Equity Efforts in the Peach State- The Atlanta Black Pride Story
Stories from the Mpox Response
Partner ReSources
Mpox Vaccine Locator (mpoxvaxmap.org)
CDC/IDSA Clinician Call: Updates & Emerging Issues on COVID-19 and Mpox
ASPR: JYNNEOS Mpox Vaccine Distribution by Jurisdiction
ASPR: Operational Planning Guide
Study of Tecovirimat for Human Mpox Virus (STOMP)
FDA: Emergency Use Authorization Fact Sheet
HHS amends PREP Act declaration increasing workforce authorized to administer mpox vaccines
HHS: Public Readiness and Emergency Preparedness (PREP) Act Coverage for Mpox
HHS: Statement From HHS Secretary Becerra on mpox
HHS: U.S. Government Mpox Research Summary
HIV.gov: Addressing Mpox Holistically
HIV.gov: Mpox and People with HIV Videos
NIH: U.S. Clinical Trial Evaluating Antiviral for Mpox Begins
PREP Act Coverage Frequently Asked Questions for Mpox
SAMHSA: Anxiety and Stress Related to Mpox
The White House: A Comprehensive Summary of Federally-Funded Mpox Research Projects
The White House: Mpox Press Briefing (9/28/2022)
WHO: Clinical Management and Infection Prevention and Control of Mpox